2m 2m 2m 2m 2m 2m 2m
BioAtla (BCAB)
NASDAQ
$3.36-$0.17 (-4.96%)
Price as of Jun 03, 2026 6:35 PM EDT- $6.5MMarket Cap
- -86.50%1-Year Change
- BiotechnologyIndustry
BioAtla (BCAB)
$3.36-$0.17 (-4.96%)
BCAB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.53 | ||
Change | $0.00 (0.00%) | ||
Open | $3.53 | ||
High | $3.75 | ||
Low | $3.53 | ||
Previous Close | $3.53 | ||
Volume | 22,420 | ||
30-Day Average Volume | 35,339 | ||
1-Week Change | -9.72% | ||
1-Month Change | -17.33% | ||
1-Year Change | -86.50% | ||
3-Year Change | -97.97% | ||
5-Year Change | -99.83% | ||
Fundamentals | |||
Shares Outstanding | 1.7M | ||
Total Assets | $8.6M | ||
Market Cap | $6.5M | ||
Enterprise Value | $4.6M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$6.3M | ||
Free Cash Flow | -$5.3M | ||
EBIT | -$6.3M | ||
EBITDA | -$6.2M | ||
Net Working Capital | -$17.6M | ||
EPS | -$211.00 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -0 | ||
P/E | -0 | ||
PEG | 0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 50 | ||
Last Split Date | 04/06/2026 | ||
Earnings & Revenue